ABERRATIONS OF EYES IN NORMAL AND CLINICAL POPULATIONS
ABERRATIONS OF EYES IN NORMAL AND CLINICAL POPULATIONS
批准号:
6044829
负责人:
RAYMOND A APPLEGATE
金额:
$30.71万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-04-01 至 2004-02-29
关键词:
aging biomarker biomedical equipment development blindness cataract cataract surgery clinical biomedical equipment clinical research cornea disorder disease /disorder prevention /control early diagnosis eye disorder chemotherapy eye disorder diagnosis eye refractometry human subject longitudinal human study mathematical model noninvasive diagnosis radial keratotomy visual perception
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted From The Applicant's Abstract): In the United States,
cataract surgery is the most frequently performed surgical procedure among 30
million Medicare beneficiaries at an estimated cost of $3.5 billion per year.
In the Baltimore Eye Survey, cataract is reported as the leading cause of
blindness in those over the age of 40, and to be four times more common in
African-Americans than in Caucasian-Americans. In the world, cataract is the
leading cause of blindness. The proposed research is designed to take a
significant step toward reducing blindness resulting from cataract. To evaluate
the effectiveness of preventative therapy designed to delay or prevent cataract
formation, new sensitive markers of early cataract development and progression
need to be identified. This need is specifically recognized and reflected in
Objective 1 of the Report of the Lens and Cataract Panel in: Vision Research, A
National Plan: 1999-2003. Objective 1 of the NEI report is to: "Determine if
there are novel markers that differentiate the normal aging process from the
diseased (cataractous) state." To meet objective 1, the Report identifies the
need for the development of "morphological and optical markers that can be
visualized by noninvasive techniques." The specific aims of the resubmission
are to demonstrate that: wavefront sensing can quantify the optical aberrations
and local scattering properties of early cataract formation; wavefront sensing
can differentiate the normal aging process from the cataractous state;
wavefront sensing has the accuracy and precision to be an effective monitoring
tool in longitudinal studies of new therapy designed to delay, prevent, or slow
cataract formation and progression. These specific aims will be accomplished by
modifying Hartmann/Shack wavefront sensor technology to quantify the optical
aberrations and local scattering properties of eyes with early cataract and
eyes of normals in the 4th, 5th and 6th decades of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optical Aberration and Visual Performance for Highly Aberrated Eyes
-
批准号:9272397
-
项目类别:
-
资助金额:$37.22万
-
财政年份:2009
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
Optical aberration and visual performance in highly aberrated eyes
-
批准号:8244513
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2009
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
Optical aberration and visual performance in highly aberrated eyes
-
批准号:8039081
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2009
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
Optical aberration and visual performance in highly aberrated eyes
-
批准号:7652856
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
Optical aberration and visual performance in highly aberrated eyes
-
批准号:7797396
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2009
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
CORE--INSTRUMENT DESIGN
-
批准号:6721598
-
项目类别:
-
资助金额:$49.42万
-
财政年份:2003
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
Instrument Design Module
-
批准号:10438655
-
项目类别:
-
资助金额:$20.4万
-
财政年份:1997
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
Instrument Design Module
-
批准号:10194500
-
项目类别:
-
资助金额:$20.4万
-
财政年份:1997
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
ENTOPTIC ASSESSMENT OF THE RETINAL VASCULATURE
-
批准号:2163790
-
项目类别:
-
资助金额:$15.11万
-
财政年份:1994
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
ENTOPTIC ASSESSMENT OF THE RETINAL VASCULATURE
-
批准号:2163792
-
项目类别:
-
资助金额:$16.43万
-
财政年份:1994
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
ENTOPTIC ASSESSMENT OF THE RETINAL VASCULATURE
-
批准号:2163791
-
项目类别:
-
资助金额:$16.02万
-
财政年份:1994
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
ABERRATIONS OF EYES IN NORMAL AND CLINICAL POPULATIONS
-
批准号:2608617
-
项目类别:
-
资助金额:$21.23万
-
财政年份:1991
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
ABERRATIONS OF EYES IN NORMAL CLINICAL POPULATION
-
批准号:2162311
-
项目类别:
-
资助金额:$22.78万
-
财政年份:1991
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
ABERRATIONS OF EYES IN NORMAL AND CLINICAL POPULATIONS
-
批准号:2162308
-
项目类别:
-
资助金额:$16.09万
-
财政年份:1991
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
ABERRATIONS OF EYES IN NORMAL AND CLINICAL POPULATIONS
-
批准号:3265861
-
项目类别:
-
资助金额:$0.99万
-
财政年份:1991
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
Aberrations of eyes in normal and clinical populations
-
批准号:7038108
-
项目类别:
-
资助金额:$36.19万
-
财政年份:1991
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
ABERRATIONS OF EYES IN NORMAL CLINICAL POPULATION
-
批准号:2019744
-
项目类别:
-
资助金额:$19.91万
-
财政年份:1991
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
ABERRATIONS OF EYES IN NORMAL AND CLINICAL POPULATIONS
-
批准号:3265859
-
项目类别:
-
资助金额:$16.26万
-
财政年份:1991
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
Aberrations of eyes in normal and clinical populations
-
批准号:7350134
-
项目类别:
-
资助金额:$34.88万
-
财政年份:1991
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
Aberrations of eyes in normal and clinical populations
-
批准号:7580925
-
项目类别:
-
资助金额:$35.7万
-
财政年份:1991
-
负责人:RAYMOND A APPLEGATE
-
依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
-
批准号:61602201
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:周雄辉
-
依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
-
批准号:81170309
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:颜桥
-
依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
-
批准号:30672394
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:陆豪杰
-
依托单位: